Literature DB >> 34311164

Diagnosis of liver cancer by FTIR spectra of serum.

Xien Yang1, Quanhong Ou1, Weiye Yang2, Youming Shi3, Gang Liu4.   

Abstract

Liver cancer is the most common fatal malignant tumor in the world. Early diagnosis of liver cancer can improve the survival rate of the patients with liver disease. In this paper, Fourier transform infrared (FTIR) spectroscopy combined with curve fitting and chemometrics was used to distinguish the serum from patients from that of healthy people. The curve fitting results in protein range of 1700-1600 cm-1 showed that there were differences in the secondary structure of protein in serum between the patients with liver cancer and healthy people. Principal component analysis (PCA) in lipid range of 2900-2800 cm-1 could distinguish the serum of patients with liver cancer from that of healthy people. The first two principal components PC1 and PC2 explained 95% of the total data variance. The sensitivity and specificity of partial least squares discriminant analysis (PLS-DA) in lipid range of 2900-2800 cm-1 reached 92.85% and 95.23% respectively. It is shown that FTIR spectroscopy might be developed as an effective method for the diagnosis of liver cancer.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Curve fitting; FTIR spectroscopy; Liver cancer; Partial least squares discriminant analysis; Principal component analysis; Serum

Year:  2021        PMID: 34311164     DOI: 10.1016/j.saa.2021.120181

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  2 in total

1.  Lymphatic filarial serum proteome profiling for identification and characterization of diagnostic biomarkers.

Authors:  Vipin Kumar; Ayushi Mishra; Awadehesh Kumar Yadav; Sushma Rathaur; Anchal Singh
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

2.  Diagnosis of Lung Cancer by FTIR Spectroscopy Combined With Raman Spectroscopy Based on Data Fusion and Wavelet Transform.

Authors:  Xien Yang; Zhongyu Wu; Quanhong Ou; Kai Qian; Liqin Jiang; Weiye Yang; Youming Shi; Gang Liu
Journal:  Front Chem       Date:  2022-01-26       Impact factor: 5.221

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.